Escherichia coli enteroaggregative

Steiner TS, Lima AAM, Nataro JP, Guerrant RL Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis 1998 177 88-96. [Pg.32]

Nataro JP, DengY, ManevalDR, German AL, Martin WC, Levine MM Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun 1992 60 2297-2304. [Pg.33]

Nataro JP, Yikang D, Giron JA, Savarino SJ, Kothary MH, Hall R Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun 1993 61 1126-1131. [Pg.33]

Savarino SJ, Fasano A, Watson J, Martin BM, Levine MM, Guandalini S, Guerry P Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin. Proc Natl Acad Sci USA 1993 90 3093-3097. [Pg.33]

Nataro JP, Deng Y, Cookson S, Cravioto A, Savarino SJ, Guers LD, Irvine MM, Tacket CO Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis 1995,171 465-468. [Pg.33]

Baldwin TJ, Knutton S, Sellers L, Hernandez HA, Aitken A, Williams PH Enteroaggregative Escherichia coli strains secrete a heat-labile toxin antigenically related to E. coli hemolysin. Infect Immun 1992,60 2092-2095. [Pg.33]

Navarro-Garcia F, Eslava C, Villaseca JM, Lo-pez-Revilla R, Czeczulin JR, Srinivas S, Nataro JP, Cravioto A In vitro effects of a high-molecular-weight heat-labile enterotoxin from enteroaggregative Escherichia coli. Infect Immun 1998,66 3149-3154. [Pg.33]

Navarro-Garcia F, Canizalez-Roman A, Luna J, Sears C, Nataro JP Plasmid-encoded toxin of enteroaggregative Escherichia coli is internalized by epithelial cells. Infect Immun 2001 69 1053-1060. [Pg.33]

After the submission of this paper several publications have appeared in the literature that reinforce the role of rifaximin in the treatment of infectious diarrhea [1]. An entire issue of the Journal of Travel Medicine devoted to the use of this antibiotic in the treatment of traveler s diarrhea (TD) has been published [2-5], In addition, a recent paper from our laboratory [6] confirmed the rifaximin efficacy also in enteroaggregative Escherichia coli-mediated TD. Furthermore, in a randomized, double-blind, placebo-con-trolled study [7] even once daily administration of the antibiotic proved to be capable of preventing TD. Finally, Lawler and Wallace [8] recently reviewed the treatment options for bacterial diarrhea and considered rifaximin a useful addition to our therapeutic armamentarium. [Pg.80]

Infante RM, Ericsson CD, Jiang ZD, Ke S, Steffen R, Riopel L, Sack DA, DuPont HL Enteroaggregative Escherichia coli diarrhea in travelers Response to rifaximin therapy. Clin Gastroenterol Hepatol 2004 2 135-138. [Pg.80]

Scavia, G., Staffolani, M., Fisichella, S., Striano, G., Colletta, S., Ferri, G., Escher, M., Minelli, F., and Caprioli, A. (2008). Enteroaggregative Escherichia coli associated with a foodborne outbreak of gastroenteritis. ]. Med. Microbiol. 57,1141-1146. [Pg.205]

Harrington SM, Dudley EG, NataroJP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006 254 12-18. [Pg.520]

Schmidt H, KnopC, FrankeS, AleksicS, HeesemannJ, Karch H (1995). Development of PCR for screening of enteroaggregative Escherichia coli. J. Clin. Microbiol, Mar., 33... [Pg.132]

Jabbour RE, Deshpande SV, McCubbin PE, et al. Extracellular protein biomarkers for the ehar-acterization of enterohemorrhagic and enteroaggregative Escherichia coli strains. J Mierobiol Methods. 2014 98 76-83. doi 10.1016/j.mimet.2013.12.017. [Pg.142]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...